Boston Scientific Corp Stock Return On Asset

BSX Stock

USD 72.72 0.71 0.97%

Boston Scientific Corp fundamentals help investors to digest information that contributes to Boston Scientific's financial success or failures. It also enables traders to predict the movement of Boston Stock. The fundamental analysis module provides a way to measure Boston Scientific's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Boston Scientific stock.

Short Long Term Debt Total Total Assets

Return On Assets is likely to rise to 0.05 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Boston Scientific Corp Company Return On Asset Analysis

Boston Scientific's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Boston Scientific Return On Asset

0.0454

Most of Boston Scientific's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Boston Scientific Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Boston Return On Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for Boston Scientific is extremely important. It helps to project a fair market value of Boston Stock properly, considering its historical fundamentals such as Return On Asset. Since Boston Scientific's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Boston Scientific's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Boston Scientific's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Short Term Investments	Common Stock	Long Term Debt	Good Will	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.97	0.94	0.5	0.89	0.94	0.77	0.83	0.1	0.59	0.78	0.66	0.87	0.9	-0.75	0.83	-0.45	0.77	0.69	0.79	-0.59	0.66	-0.03	0.66	0.87	0.8	0.7
Total Stockholder Equity	0.97		0.87	0.65	0.9	0.88	0.65	0.78	0.01	0.43	0.77	0.53	0.82	0.89	-0.65	0.81	-0.37	0.85	0.74	0.83	-0.49	0.6	-0.1	0.7	0.91	0.84	0.78
Net Debt	0.94	0.87		0.41	0.83	0.93	0.82	0.79	0.32	0.64	0.84	0.65	0.87	0.82	-0.78	0.77	-0.55	0.64	0.69	0.69	-0.66	0.74	0.17	0.51	0.82	0.71	0.56
Retained Earnings	0.5	0.65	0.41		0.59	0.3	0.05	0.3	-0.13	-0.31	0.57	-0.23	0.4	0.46	-0.12	0.4	-0.18	0.71	0.78	0.66	-0.07	0.36	-0.16	0.6	0.79	0.72	0.69
Accounts Payable	0.89	0.9	0.83	0.59		0.89	0.58	0.7	0.12	0.3	0.85	0.52	0.72	0.79	-0.74	0.78	-0.52	0.82	0.69	0.85	-0.67	0.58	-0.02	0.64	0.86	0.77	0.8
Net Receivables	0.94	0.88	0.93	0.3	0.89		0.76	0.73	0.27	0.67	0.77	0.75	0.76	0.83	-0.76	0.8	-0.46	0.67	0.52	0.7	-0.7	0.57	0.14	0.43	0.73	0.6	0.64
Total Liab	0.77	0.65	0.82	0.05	0.58	0.76		0.92	0.25	0.84	0.59	0.85	0.9	0.83	-0.78	0.82	-0.56	0.35	0.55	0.58	-0.58	0.62	0.09	0.48	0.6	0.58	0.29
Total Current Assets	0.83	0.78	0.79	0.3	0.7	0.73	0.92		0.1	0.62	0.68	0.75	0.93	0.89	-0.82	0.89	-0.54	0.59	0.72	0.8	-0.58	0.71	-0.06	0.75	0.77	0.81	0.53
Short Term Debt	0.1	0.01	0.32	-0.13	0.12	0.27	0.25	0.1		0.28	0.51	0.13	-0.01	0.08	-0.17	0.09	-0.23	-0.18	-0.11	-0.03	-0.28	0.22	0.97	-0.24	0.02	-0.12	-0.1
Intangible Assets	0.59	0.43	0.64	-0.31	0.3	0.67	0.84	0.62	0.28		0.27	0.86	0.61	0.61	-0.52	0.55	-0.29	0.05	0.1	0.18	-0.38	0.3	0.19	0.07	0.22	0.16	0.01
Short Term Investments	0.78	0.77	0.84	0.57	0.85	0.77	0.59	0.68	0.51	0.27		0.37	0.66	0.68	-0.68	0.66	-0.62	0.66	0.67	0.73	-0.66	0.77	0.38	0.58	0.81	0.74	0.61
Common Stock	0.66	0.53	0.65	-0.23	0.52	0.75	0.85	0.75	0.13	0.86	0.37		0.68	0.7	-0.73	0.72	-0.45	0.3	0.25	0.47	-0.63	0.42	-0.02	0.28	0.34	0.33	0.3
Long Term Debt	0.87	0.82	0.87	0.4	0.72	0.76	0.9	0.93	-0.01	0.61	0.66	0.68		0.88	-0.79	0.85	-0.58	0.61	0.83	0.76	-0.57	0.73	-0.17	0.72	0.84	0.83	0.51
Good Will	0.9	0.89	0.82	0.46	0.79	0.83	0.83	0.89	0.08	0.61	0.68	0.7	0.88		-0.64	0.95	-0.42	0.66	0.72	0.82	-0.47	0.54	-0.04	0.63	0.81	0.75	0.64
Treasury Stock	-0.75	-0.65	-0.78	-0.12	-0.74	-0.76	-0.78	-0.82	-0.17	-0.52	-0.68	-0.73	-0.79	-0.64		-0.69	0.58	-0.55	-0.54	-0.66	0.84	-0.72	0.03	-0.61	-0.65	-0.68	-0.45
Property Plant Equipment	0.83	0.81	0.77	0.4	0.78	0.8	0.82	0.89	0.09	0.55	0.66	0.72	0.85	0.95	-0.69		-0.45	0.68	0.72	0.87	-0.54	0.5	-0.04	0.56	0.79	0.72	0.68
Current Deferred Revenue	-0.45	-0.37	-0.55	-0.18	-0.52	-0.46	-0.56	-0.54	-0.23	-0.29	-0.62	-0.45	-0.58	-0.42	0.58	-0.45		-0.27	-0.48	-0.4	0.71	-0.64	-0.11	-0.41	-0.47	-0.49	-0.17
Net Tangible Assets	0.77	0.85	0.64	0.71	0.82	0.67	0.35	0.59	-0.18	0.05	0.66	0.3	0.61	0.66	-0.55	0.68	-0.27		0.71	0.85	-0.45	0.57	-0.27	0.65	0.83	0.82	0.87
Long Term Debt Total	0.69	0.74	0.69	0.78	0.69	0.52	0.55	0.72	-0.11	0.1	0.67	0.25	0.83	0.72	-0.54	0.72	-0.48	0.71		0.85	-0.38	0.68	-0.24	0.76	0.92	0.89	0.68
Capital Surpluse	0.79	0.83	0.69	0.66	0.85	0.7	0.58	0.8	-0.03	0.18	0.73	0.47	0.76	0.82	-0.66	0.87	-0.4	0.85	0.85		-0.54	0.59	-0.16	0.76	0.89	0.86	0.91
Deferred Long Term Liab	-0.59	-0.49	-0.66	-0.07	-0.67	-0.7	-0.58	-0.58	-0.28	-0.38	-0.66	-0.63	-0.57	-0.47	0.84	-0.54	0.71	-0.45	-0.38	-0.54		-0.62	-0.13	-0.37	-0.49	-0.46	-0.41
Long Term Investments	0.66	0.6	0.74	0.36	0.58	0.57	0.62	0.71	0.22	0.3	0.77	0.42	0.73	0.54	-0.72	0.5	-0.64	0.57	0.68	0.59	-0.62		0.06	0.65	0.67	0.75	0.41
Short Long Term Debt	-0.03	-0.1	0.17	-0.16	-0.02	0.14	0.09	-0.06	0.97	0.19	0.38	-0.02	-0.17	-0.04	0.03	-0.04	-0.11	-0.27	-0.24	-0.16	-0.13	0.06		-0.36	-0.1	-0.25	-0.18
Cash And Equivalents	0.66	0.7	0.51	0.6	0.64	0.43	0.48	0.75	-0.24	0.07	0.58	0.28	0.72	0.63	-0.61	0.56	-0.41	0.65	0.76	0.76	-0.37	0.65	-0.36		0.78	0.92	0.6
Net Invested Capital	0.87	0.91	0.82	0.79	0.86	0.73	0.6	0.77	0.02	0.22	0.81	0.34	0.84	0.81	-0.65	0.79	-0.47	0.83	0.92	0.89	-0.49	0.67	-0.1	0.78		0.94	0.77
Net Working Capital	0.8	0.84	0.71	0.72	0.77	0.6	0.58	0.81	-0.12	0.16	0.74	0.33	0.83	0.75	-0.68	0.72	-0.49	0.82	0.89	0.86	-0.46	0.75	-0.25	0.92	0.94		0.69
Capital Stock	0.7	0.78	0.56	0.69	0.8	0.64	0.29	0.53	-0.1	0.01	0.61	0.3	0.51	0.64	-0.45	0.68	-0.17	0.87	0.68	0.91	-0.41	0.41	-0.18	0.6	0.77	0.69

Click cells to compare fundamentals

Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.

Competition

Predict Boston Scientific

Boston Total Assets

Total Assets

36.89 Billion

At this time, Boston Scientific's Total Assets are fairly stable compared to the past year.

Based on the latest financial disclosure, Boston Scientific Corp has a Return On Asset of 0.0454. This is 100.52% lower than that of the Health Care Equipment & Supplies sector and 100.25% lower than that of the Health Care industry. The return on asset for all United States stocks is 132.43% lower than that of the firm.

Boston Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Boston Scientific's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Boston Scientific could also be used in its relative valuation, which is a method of valuing Boston Scientific by comparing valuation metrics of similar companies.

Boston Scientific is currently under evaluation in return on asset category among related companies.

Boston Scientific ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Boston Scientific's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Boston Scientific's managers, analysts, and investors.

Environment Score

Governance Score

Social Score

Boston Fundamentals

	Return On Equity	0.0925
	Return On Asset	0.0454
	Profit Margin	0.12 %
	Operating Margin	0.18 %
	Current Valuation	116.87 B
	Shares Outstanding	1.47 B
	Shares Owned By Insiders	0.19 %
	Shares Owned By Institutions	94.57 %
	Number Of Shares Shorted	13.16 M
	Price To Earning	107.05 X
	Price To Book	5.19 X
	Price To Sales	7.03 X
	Revenue	14.24 B
	Gross Profit	8.68 B
	EBITDA	3.62 B
	Net Income	1.59 B
	Cash And Equivalents	928 M
	Cash Per Share	0.24 X
	Total Debt	9.49 B
	Debt To Equity	0.51 %
	Current Ratio	1.45 X
	Book Value Per Share	13.55 X
	Cash Flow From Operations	2.5 B
	Short Ratio	2.50 X
	Earnings Per Share	1.19 X
	Price To Earnings To Growth	1.80 X
	Target Price	81.86
	Number Of Employees	48 K
	Beta	0.79
	Market Capitalization	107.96 B
	Total Asset	35.14 B
	Retained Earnings	819 M
	Working Capital	1.58 B
	Current Asset	1.21 B
	Current Liabilities	923 M
	Net Asset	35.14 B

About Boston Scientific Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Boston Scientific Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Boston Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Boston Scientific Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Boston Scientific

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Boston Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boston Scientific will appreciate offsetting losses from the drop in the long position's value.

Moving together with Boston Stock

0.63	ELMD	Electromed	Pair Corr
0.62	GKOS	Glaukos Corp	Pair Corr

Moving against Boston Stock

0.87	CVRX	CVRx Inc Financial Report 23rd of July 2024	Pair Corr
0.79	IART	Integra LifeSciences	Pair Corr
0.76	CVS	CVS Health Corp	Pair Corr
0.76	INMD	InMode	Pair Corr
0.74	MASS	908 Devices Financial Report 14th of May 2024	Pair Corr

The ability to find closely correlated positions to Boston Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Boston Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Boston Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Boston Scientific Corp to buy it.

The correlation of Boston Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Boston Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Boston Scientific Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Boston Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Boston Scientific Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Boston Scientific's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Boston Scientific Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Boston Scientific Corp Stock:

How To Invest In Boston

Details

Is Boston Stock a good investment?

Details

What is Boston Scientific's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Boston Scientific Piotroski F Score and Boston Scientific Altman Z Score analysis.

You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Boston Stock analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.

	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk

Is Boston Scientific's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boston Scientific. If investors know Boston will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boston Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.579

Earnings Share

1.19

Revenue Per Share

10.065

Quarterly Revenue Growth

0.138

Return On Assets

0.0454

The market value of Boston Scientific Corp is measured differently than its book value, which is the value of Boston that is recorded on the company's balance sheet. Investors also form their own opinion of Boston Scientific's value that differs from its market value or its book value, called intrinsic value, which is Boston Scientific's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boston Scientific's market value can be influenced by many factors that don't directly affect Boston Scientific's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Boston Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Boston Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boston Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Boston Scientific Corp Stock Return On Asset

Boston Scientific Corp Company Return On Asset Analysis

Return On Asset

Net Income

Total Assets

Current Boston Scientific Return On Asset

Boston Return On Asset Driver Correlations

Boston Total Assets

Total Assets

36.89 Billion

Boston Return On Asset Peer Comparison

Boston Scientific ESG Sustainability

Boston Fundamentals

About Boston Scientific Fundamental Analysis

Pair Trading with Boston Scientific

Moving together with Boston Stock

Moving against Boston Stock

Complementary Tools for Boston Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY